APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Desloratadine Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Research

Desloratadine Tablets Industry Research Report 2026

Report ID 173983700528 December 2025138 pages

Choose your research edition.

Industry ResearchDesloratadine Tablets Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Desloratadine Tablets Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Desloratadine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Desloratadine Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Desloratadine Tablets Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Desloratadine Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Desloratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Desloratadine Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Desloratadine Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Desloratadine Tablets include Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical, Yangtze River Pharmaceutical Group, Shenzhen Salubris Pharmaceuticals, Guangdong Jiuming pharmaceutical, Yingtai Pharma, Poly Pharm, Sinopharm Group Pharmaceuticals, FangYuan Pharmaceutical and Torrent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Desloratadine Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Desloratadine Tablets Market by Company

Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical

Yangtze River Pharmaceutical Group

Shenzhen Salubris Pharmaceuticals

Guangdong Jiuming pharmaceutical

Yingtai Pharma

Poly Pharm

Sinopharm Group Pharmaceuticals

FangYuan Pharmaceutical

Torrent Pharmaceuticals

Teva Pharmaceutical Industries

Sun Pharmaceutical Industries

Sandoz International GmbH

Perrigo Company plc

Organon Pharma

Mylan

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

Apotex

Desloratadine Tablets Segment by Type

Ordinary Tablets

Dispersible Tablets

Other

Desloratadine Tablets Segment by Application

Specialist Medical Centre

Hospital and Clinic

Retail Pharmacies

Other

Desloratadine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Desloratadine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Desloratadine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Desloratadine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Desloratadine Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Desloratadine Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Desloratadine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Desloratadine Tablets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Desloratadine Tablets Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Desloratadine Tablets Sales Market Share by Manufacturers (2021-2026) Table 8. Global Desloratadine Tablets Revenue of Manufacturers (2021-2026) Table 9. Global Desloratadine Tablets Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Desloratadine Tablets Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Desloratadine Tablets Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Desloratadine Tablets, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Desloratadine Tablets, Product Type & Application Table 14. Global Desloratadine Tablets Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Desloratadine Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Company Information Table 19. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Business Overview Table 20. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Product Portfolio Table 22. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Developments Table 23. Yangtze River Pharmaceutical Group Company Information Table 24. Yangtze River Pharmaceutical Group Business Overview Table 25. Yangtze River Pharmaceutical Group Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Yangtze River Pharmaceutical Group Desloratadine Tablets Product Portfolio Table 27. Yangtze River Pharmaceutical Group Recent Developments Table 28. Shenzhen Salubris Pharmaceuticals Company Information Table 29. Shenzhen Salubris Pharmaceuticals Business Overview Table 30. Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Product Portfolio Table 32. Shenzhen Salubris Pharmaceuticals Recent Developments Table 33. Guangdong Jiuming pharmaceutical Company Information Table 34. Guangdong Jiuming pharmaceutical Business Overview Table 35. Guangdong Jiuming pharmaceutical Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Guangdong Jiuming pharmaceutical Desloratadine Tablets Product Portfolio Table 37. Guangdong Jiuming pharmaceutical Recent Developments Table 38. Yingtai Pharma Company Information Table 39. Yingtai Pharma Business Overview Table 40. Yingtai Pharma Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Yingtai Pharma Desloratadine Tablets Product Portfolio Table 42. Yingtai Pharma Recent Developments Table 43. Poly Pharm Company Information Table 44. Poly Pharm Business Overview Table 45. Poly Pharm Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Poly Pharm Desloratadine Tablets Product Portfolio Table 47. Poly Pharm Recent Developments Table 48. Sinopharm Group Pharmaceuticals Company Information Table 49. Sinopharm Group Pharmaceuticals Business Overview Table 50. Sinopharm Group Pharmaceuticals Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Sinopharm Group Pharmaceuticals Desloratadine Tablets Product Portfolio Table 52. Sinopharm Group Pharmaceuticals Recent Developments Table 53. FangYuan Pharmaceutical Company Information Table 54. FangYuan Pharmaceutical Business Overview Table 55. FangYuan Pharmaceutical Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. FangYuan Pharmaceutical Desloratadine Tablets Product Portfolio Table 57. FangYuan Pharmaceutical Recent Developments Table 58. Torrent Pharmaceuticals Company Information Table 59. Torrent Pharmaceuticals Business Overview Table 60. Torrent Pharmaceuticals Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Torrent Pharmaceuticals Desloratadine Tablets Product Portfolio Table 62. Torrent Pharmaceuticals Recent Developments Table 63. Teva Pharmaceutical Industries Company Information Table 64. Teva Pharmaceutical Industries Business Overview Table 65. Teva Pharmaceutical Industries Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Industries Desloratadine Tablets Product Portfolio Table 67. Teva Pharmaceutical Industries Recent Developments Table 68. Sun Pharmaceutical Industries Company Information Table 69. Sun Pharmaceutical Industries Business Overview Table 70. Sun Pharmaceutical Industries Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sun Pharmaceutical Industries Desloratadine Tablets Product Portfolio Table 72. Sun Pharmaceutical Industries Recent Developments Table 73. Sandoz International GmbH Company Information Table 74. Sandoz International GmbH Business Overview Table 75. Sandoz International GmbH Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sandoz International GmbH Desloratadine Tablets Product Portfolio Table 77. Sandoz International GmbH Recent Developments Table 78. Perrigo Company plc Company Information Table 79. Perrigo Company plc Business Overview Table 80. Perrigo Company plc Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Perrigo Company plc Desloratadine Tablets Product Portfolio Table 82. Perrigo Company plc Recent Developments Table 83. Organon Pharma Company Information Table 84. Organon Pharma Business Overview Table 85. Organon Pharma Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Organon Pharma Desloratadine Tablets Product Portfolio Table 87. Organon Pharma Recent Developments Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mylan Desloratadine Tablets Product Portfolio Table 92. Mylan Recent Developments Table 93. Glenmark Pharmaceuticals Company Information Table 94. Glenmark Pharmaceuticals Business Overview Table 95. Glenmark Pharmaceuticals Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Glenmark Pharmaceuticals Desloratadine Tablets Product Portfolio Table 97. Glenmark Pharmaceuticals Recent Developments Table 98. Dr. Reddy's Laboratories Company Information Table 99. Dr. Reddy's Laboratories Business Overview Table 100. Dr. Reddy's Laboratories Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Dr. Reddy's Laboratories Desloratadine Tablets Product Portfolio Table 102. Dr. Reddy's Laboratories Recent Developments Table 103. Apotex Company Information Table 104. Apotex Business Overview Table 105. Apotex Desloratadine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Apotex Desloratadine Tablets Product Portfolio Table 107. Apotex Recent Developments Table 108. Global Desloratadine Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Desloratadine Tablets Sales by Region (2021-2026) & (K Units) Table 110. Global Desloratadine Tablets Sales Market Share by Region (2021-2026) Table 111. Global Desloratadine Tablets Sales by Region (2027-2032) & (K Units) Table 112. Global Desloratadine Tablets Sales Market Share by Region (2027-2032) Table 113. Global Desloratadine Tablets Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Desloratadine Tablets Revenue Market Share by Region (2021-2026) Table 115. Global Desloratadine Tablets Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Desloratadine Tablets Revenue Market Share by Region (2027-2032) Table 117. North America Desloratadine Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Desloratadine Tablets Sales by Country (2021-2026) & (K Units) Table 119. North America Desloratadine Tablets Sales by Country (2027-2032) & (K Units) Table 120. North America Desloratadine Tablets Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Desloratadine Tablets Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Desloratadine Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Desloratadine Tablets Sales by Country (2021-2026) & (K Units) Table 124. Europe Desloratadine Tablets Sales by Country (2027-2032) & (K Units) Table 125. Europe Desloratadine Tablets Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Desloratadine Tablets Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Desloratadine Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Desloratadine Tablets Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Desloratadine Tablets Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Desloratadine Tablets Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Desloratadine Tablets Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Desloratadine Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Desloratadine Tablets Sales by Country (2021-2026) & (K Units) Table 134. South America Desloratadine Tablets Sales by Country (2027-2032) & (K Units) Table 135. South America Desloratadine Tablets Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Desloratadine Tablets Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Desloratadine Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Desloratadine Tablets Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Desloratadine Tablets Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Desloratadine Tablets Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Desloratadine Tablets Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Desloratadine Tablets Sales by Type (2021-2026) & (K Units) Table 143. Global Desloratadine Tablets Sales by Type (2027-2032) & (K Units) Table 144. Global Desloratadine Tablets Sales Market Share by Type (2021-2026) Table 145. Global Desloratadine Tablets Sales Market Share by Type (2027-2032) Table 146. Global Desloratadine Tablets Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Desloratadine Tablets Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Desloratadine Tablets Revenue Market Share by Type (2021-2026) Table 149. Global Desloratadine Tablets Revenue Market Share by Type (2027-2032) Table 150. Global Desloratadine Tablets Price by Type (2021-2026) & (US$/Unit) Table 151. Global Desloratadine Tablets Price by Type (2027-2032) & (US$/Unit) Table 152. Global Desloratadine Tablets Sales by Application (2021-2026) & (K Units) Table 153. Global Desloratadine Tablets Sales by Application (2027-2032) & (K Units) Table 154. Global Desloratadine Tablets Sales Market Share by Application (2021-2026) Table 155. Global Desloratadine Tablets Sales Market Share by Application (2027-2032) Table 156. Global Desloratadine Tablets Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Desloratadine Tablets Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Desloratadine Tablets Revenue Market Share by Application (2021-2026) Table 159. Global Desloratadine Tablets Revenue Market Share by Application (2027-2032) Table 160. Global Desloratadine Tablets Price by Application (2021-2026) & (US$/Unit) Table 161. Global Desloratadine Tablets Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Desloratadine Tablets Distributors List Table 165. Desloratadine Tablets Customers List Table 166. Desloratadine Tablets Industry Trends Table 167. Desloratadine Tablets Industry Drivers Table 168. Desloratadine Tablets Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Desloratadine Tablets Product Image Figure 5. Global Desloratadine Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Desloratadine Tablets Market Size (2021-2032) & (US$ Million) Figure 7. Global Desloratadine Tablets Sales (2021-2032) & (K Units) Figure 8. Global Desloratadine Tablets Average Price (US$/Unit) & (2021-2032) Figure 9. Ordinary Tablets Product Image Figure 10. Dispersible Tablets Product Image Figure 11. Other Product Image Figure 12. Specialist Medical Centre Product Image Figure 13. Hospital and Clinic Product Image Figure 14. Retail Pharmacies Product Image Figure 15. Other Product Image Figure 16. Global Desloratadine Tablets Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Desloratadine Tablets, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Desloratadine Tablets Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Desloratadine Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Desloratadine Tablets Sales by Region in 2025 Figure 22. Global Desloratadine Tablets Revenue by Region in 2025 Figure 23. North America Desloratadine Tablets Market Size by Country in 2025 Figure 24. North America Desloratadine Tablets Sales Market Share by Country (2021-2032) Figure 25. North America Desloratadine Tablets Revenue Market Share by Country (2021-2032) Figure 26. United States Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Desloratadine Tablets Market Size by Country in 2025 Figure 30. Europe Desloratadine Tablets Sales Market Share by Country (2021-2032) Figure 31. Europe Desloratadine Tablets Revenue Market Share by Country (2021-2032) Figure 32. Germany Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Desloratadine Tablets Market Size by Country in 2025 Figure 43. Asia Pacific Desloratadine Tablets Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Desloratadine Tablets Revenue Market Share by Country (2021-2032) Figure 45. China Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Desloratadine Tablets Market Size by Country in 2025 Figure 54. South America Desloratadine Tablets Sales Market Share by Country (2021-2032) Figure 55. South America Desloratadine Tablets Revenue Market Share by Country (2021-2032) Figure 56. Brazil Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Desloratadine Tablets Market Size by Country in 2025 Figure 60. Middle East and Africa Desloratadine Tablets Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Desloratadine Tablets Revenue Market Share by Country (2021-2032) Figure 62. Egypt Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Desloratadine Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Desloratadine Tablets Sales Market Share by Type (2021-2032) Figure 68. Global Desloratadine Tablets Revenue Market Share by Type (2021-2032) Figure 69. Global Desloratadine Tablets Price (US$/Unit) by Type (2021-2032) Figure 70. Global Desloratadine Tablets Sales Market Share by Application (2021-2032) Figure 71. Global Desloratadine Tablets Revenue Market Share by Application (2021-2032) Figure 72. Global Desloratadine Tablets Price (US$/Unit) by Application (2021-2032) Figure 73. Desloratadine Tablets Value Chain Figure 74. Desloratadine Tablets Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Desloratadine Tablets Industry Opportunities and Challenges

Scope & coverage.

Types
  • Ordinary Tablets
  • Dispersible Tablets
  • Other
Applications
  • Specialist Medical Centre
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • Shenzhen Salubris Pharmaceuticals
  • Guangdong Jiuming pharmaceutical
  • Yingtai Pharma
  • Poly Pharm
  • Sinopharm Group Pharmaceuticals
  • FangYuan Pharmaceutical
  • Torrent Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Sandoz International GmbH
  • Perrigo Company plc
  • Organon Pharma
  • Mylan
  • Glenmark Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Apotex

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Desloratadine Tablets Market Size (2021-2032)
  4. 2.2.2 Global Desloratadine Tablets Sales (2021-2032)
  5. 2.2.3 Global Desloratadine Tablets Market Average Price (2021-2032)
  6. 2.3 Desloratadine Tablets by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Ordinary Tablets
  9. 2.3.3 Dispersible Tablets
  10. 2.3.4 Other
  11. 2.4 Desloratadine Tablets by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Specialist Medical Centre
  14. 2.4.3 Hospital and Clinic
  15. 2.4.4 Retail Pharmacies
  16. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Desloratadine Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Desloratadine Tablets Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Desloratadine Tablets Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Desloratadine Tablets Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Desloratadine Tablets Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Desloratadine Tablets, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Desloratadine Tablets, Product Type & Application
  8. 3.8 Global Manufacturers of Desloratadine Tablets, Established Date
  9. 3.9 Global Desloratadine Tablets Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
  2. 4.1.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Company Information
  3. 4.1.2 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Business Overview
  4. 4.1.3 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Product Portfolio
  6. 4.1.5 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Developments
  7. 4.2 Yangtze River Pharmaceutical Group
  8. 4.2.1 Yangtze River Pharmaceutical Group Company Information
  9. 4.2.2 Yangtze River Pharmaceutical Group Business Overview
  10. 4.2.3 Yangtze River Pharmaceutical Group Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Yangtze River Pharmaceutical Group Desloratadine Tablets Product Portfolio
  12. 4.2.5 Yangtze River Pharmaceutical Group Recent Developments
  13. 4.3 Shenzhen Salubris Pharmaceuticals
  14. 4.3.1 Shenzhen Salubris Pharmaceuticals Company Information
  15. 4.3.2 Shenzhen Salubris Pharmaceuticals Business Overview
  16. 4.3.3 Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Product Portfolio
  18. 4.3.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  19. 4.4 Guangdong Jiuming pharmaceutical
  20. 4.4.1 Guangdong Jiuming pharmaceutical Company Information
  21. 4.4.2 Guangdong Jiuming pharmaceutical Business Overview
  22. 4.4.3 Guangdong Jiuming pharmaceutical Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Guangdong Jiuming pharmaceutical Desloratadine Tablets Product Portfolio
  24. 4.4.5 Guangdong Jiuming pharmaceutical Recent Developments
  25. 4.5 Yingtai Pharma
  26. 4.5.1 Yingtai Pharma Company Information
  27. 4.5.2 Yingtai Pharma Business Overview
  28. 4.5.3 Yingtai Pharma Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Yingtai Pharma Desloratadine Tablets Product Portfolio
  30. 4.5.5 Yingtai Pharma Recent Developments
  31. 4.6 Poly Pharm
  32. 4.6.1 Poly Pharm Company Information
  33. 4.6.2 Poly Pharm Business Overview
  34. 4.6.3 Poly Pharm Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Poly Pharm Desloratadine Tablets Product Portfolio
  36. 4.6.5 Poly Pharm Recent Developments
  37. 4.7 Sinopharm Group Pharmaceuticals
  38. 4.7.1 Sinopharm Group Pharmaceuticals Company Information
  39. 4.7.2 Sinopharm Group Pharmaceuticals Business Overview
  40. 4.7.3 Sinopharm Group Pharmaceuticals Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Sinopharm Group Pharmaceuticals Desloratadine Tablets Product Portfolio
  42. 4.7.5 Sinopharm Group Pharmaceuticals Recent Developments
  43. 4.8 FangYuan Pharmaceutical
  44. 4.8.1 FangYuan Pharmaceutical Company Information
  45. 4.8.2 FangYuan Pharmaceutical Business Overview
  46. 4.8.3 FangYuan Pharmaceutical Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 FangYuan Pharmaceutical Desloratadine Tablets Product Portfolio
  48. 4.8.5 FangYuan Pharmaceutical Recent Developments
  49. 4.9 Torrent Pharmaceuticals
  50. 4.9.1 Torrent Pharmaceuticals Company Information
  51. 4.9.2 Torrent Pharmaceuticals Business Overview
  52. 4.9.3 Torrent Pharmaceuticals Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Torrent Pharmaceuticals Desloratadine Tablets Product Portfolio
  54. 4.9.5 Torrent Pharmaceuticals Recent Developments
  55. 4.10 Teva Pharmaceutical Industries
  56. 4.10.1 Teva Pharmaceutical Industries Company Information
  57. 4.10.2 Teva Pharmaceutical Industries Business Overview
  58. 4.10.3 Teva Pharmaceutical Industries Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Teva Pharmaceutical Industries Desloratadine Tablets Product Portfolio
  60. 4.10.5 Teva Pharmaceutical Industries Recent Developments
  61. 4.11 Sun Pharmaceutical Industries
  62. 4.11.1 Sun Pharmaceutical Industries Company Information
  63. 4.11.2 Sun Pharmaceutical Industries Business Overview
  64. 4.11.3 Sun Pharmaceutical Industries Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Sun Pharmaceutical Industries Desloratadine Tablets Product Portfolio
  66. 4.11.5 Sun Pharmaceutical Industries Recent Developments
  67. 4.12 Sandoz International GmbH
  68. 4.12.1 Sandoz International GmbH Company Information
  69. 4.12.2 Sandoz International GmbH Business Overview
  70. 4.12.3 Sandoz International GmbH Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Sandoz International GmbH Desloratadine Tablets Product Portfolio
  72. 4.12.5 Sandoz International GmbH Recent Developments
  73. 4.13 Perrigo Company plc
  74. 4.13.1 Perrigo Company plc Company Information
  75. 4.13.2 Perrigo Company plc Business Overview
  76. 4.13.3 Perrigo Company plc Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Perrigo Company plc Desloratadine Tablets Product Portfolio
  78. 4.13.5 Perrigo Company plc Recent Developments
  79. 4.14 Organon Pharma
  80. 4.14.1 Organon Pharma Company Information
  81. 4.14.2 Organon Pharma Business Overview
  82. 4.14.3 Organon Pharma Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Organon Pharma Desloratadine Tablets Product Portfolio
  84. 4.14.5 Organon Pharma Recent Developments
  85. 4.15 Mylan
  86. 4.15.1 Mylan Company Information
  87. 4.15.2 Mylan Business Overview
  88. 4.15.3 Mylan Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Mylan Desloratadine Tablets Product Portfolio
  90. 4.15.5 Mylan Recent Developments
  91. 4.16 Glenmark Pharmaceuticals
  92. 4.16.1 Glenmark Pharmaceuticals Company Information
  93. 4.16.2 Glenmark Pharmaceuticals Business Overview
  94. 4.16.3 Glenmark Pharmaceuticals Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Glenmark Pharmaceuticals Desloratadine Tablets Product Portfolio
  96. 4.16.5 Glenmark Pharmaceuticals Recent Developments
  97. 4.17 Dr. Reddy's Laboratories
  98. 4.17.1 Dr. Reddy's Laboratories Company Information
  99. 4.17.2 Dr. Reddy's Laboratories Business Overview
  100. 4.17.3 Dr. Reddy's Laboratories Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Dr. Reddy's Laboratories Desloratadine Tablets Product Portfolio
  102. 4.17.5 Dr. Reddy's Laboratories Recent Developments
  103. 4.18 Apotex
  104. 4.18.1 Apotex Company Information
  105. 4.18.2 Apotex Business Overview
  106. 4.18.3 Apotex Desloratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Apotex Desloratadine Tablets Product Portfolio
  108. 4.18.5 Apotex Recent Developments
5 Global Desloratadine Tablets Market Scenario by Region
  1. 5.1 Global Desloratadine Tablets Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Desloratadine Tablets Sales by Region: 2021-2032
  3. 5.2.1 Global Desloratadine Tablets Sales by Region: 2021-2026
  4. 5.2.2 Global Desloratadine Tablets Sales by Region: 2027-2032
  5. 5.3 Global Desloratadine Tablets Revenue by Region: 2021-2032
  6. 5.3.1 Global Desloratadine Tablets Revenue by Region: 2021-2026
  7. 5.3.2 Global Desloratadine Tablets Revenue by Region: 2027-2032
  8. 5.4 North America Desloratadine Tablets Market Facts & Figures by Country
  9. 5.4.1 North America Desloratadine Tablets Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Desloratadine Tablets Sales by Country (2021-2032)
  11. 5.4.3 North America Desloratadine Tablets Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Desloratadine Tablets Market Facts & Figures by Country
  16. 5.5.1 Europe Desloratadine Tablets Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Desloratadine Tablets Sales by Country (2021-2032)
  18. 5.5.3 Europe Desloratadine Tablets Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Desloratadine Tablets Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Desloratadine Tablets Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Desloratadine Tablets Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Desloratadine Tablets Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Desloratadine Tablets Market Facts & Figures by Country
  41. 5.7.1 South America Desloratadine Tablets Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Desloratadine Tablets Sales by Country (2021-2032)
  43. 5.7.3 South America Desloratadine Tablets Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Desloratadine Tablets Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Desloratadine Tablets Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Desloratadine Tablets Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Desloratadine Tablets Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Desloratadine Tablets Sales by Type (2021-2032)
  2. 6.1.1 Global Desloratadine Tablets Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Desloratadine Tablets Sales Market Share by Type (2021-2032)
  4. 6.2 Global Desloratadine Tablets Revenue by Type (2021-2032)
  5. 6.2.1 Global Desloratadine Tablets Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Desloratadine Tablets Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Desloratadine Tablets Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Desloratadine Tablets Sales by Application (2021-2032)
  2. 7.1.1 Global Desloratadine Tablets Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Desloratadine Tablets Sales Market Share by Application (2021-2032)
  4. 7.2 Global Desloratadine Tablets Revenue by Application (2021-2032)
  5. 7.2.1 Global Desloratadine Tablets Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Desloratadine Tablets Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Desloratadine Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Desloratadine Tablets Value Chain Analysis
  2. 8.1.1 Desloratadine Tablets Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Desloratadine Tablets Production Mode & Process
  5. 8.2 Desloratadine Tablets Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Desloratadine Tablets Distributors
  8. 8.2.3 Desloratadine Tablets Customers
9 Global Desloratadine Tablets Analyzing Market Dynamics
  1. 9.1 Desloratadine Tablets Industry Trends
  2. 9.2 Desloratadine Tablets Industry Drivers
  3. 9.3 Desloratadine Tablets Industry Opportunities and Challenges
  4. 9.4 Desloratadine Tablets Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst